SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-215347
Filing Date
2019-08-07
Accepted
2019-08-07 16:16:12
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d758342d10q.htm   iXBRL 10-Q 1461988
2 EX-31.1 d758342dex311.htm EX-31.1 6453
3 EX-31.2 d758342dex312.htm EX-31.2 6405
4 EX-32 d758342dex32.htm EX-32 4975
  Complete submission text file 0001193125-19-215347.txt   6025920

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itci-20190630.xsd EX-101.SCH 31524
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20190630_cal.xml EX-101.CAL 30790
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20190630_def.xml EX-101.DEF 151665
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20190630_lab.xml EX-101.LAB 330295
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20190630_pre.xml EX-101.PRE 262909
10 EXTRACTED XBRL INSTANCE DOCUMENT d758342d10q_htm.xml XML 1259972
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 191005661
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences